WEST PHARMACEUTICAL SERVICESWST

Neutral

ASignal's systematic analysis rates WST as Neutral.

Reflects the latest available analysis · analyzed Aug 25, 2026

The case on WST

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong financial health (debt-to-equity ratio of 0.11x)
  • Healthy free cash flow of $277.94M
  • High return on equity at 19.09%
  • Positive earnings growth of 18.10% year-over-year
  • Revenue growth of 13.80% indicates solid top-line expansion
  • MACD above signal line with expanding histogram suggests strengthening momentum
VS
Bear case
  • Elevated valuation with P/E of 44.92x and forward P/E of 35.21x
  • PEG ratio of 3.03x suggests overvaluation relative to growth
  • Price near upper Bollinger Band with RSI near neutral zone
  • Negative short-term price momentum
  • Limited news coverage from only two sources (Yahoo, Zacks)
  • No Reddit mentions, indicating low retail investor interest

Peers

Clustered with WST by analysis-profile similarity.

Subscriber-only

See the full verdict on WST

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes WST

Most investors never get a second opinion, let alone several. ASignal runs WST past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

WEST PHARMACEUTICAL SERVICES (WST) Stock Analysis - ASignal rates it Neutral